These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia. Demir V; Doğru MT; Ede H; Yilmaz S; Alp C; Celik Y; Yildirim N Cardiovasc J Afr; 2018 May/Jun 23; 29(3):162-166. PubMed ID: 29528361 [TBL] [Abstract][Full Text] [Related]
6. Effects of Chinese yellow wine on nitric oxide synthase and intercellular adhesion molecule-1 expressions in rat vascular endothelial cells. Zhao F; Ji Z; Chi J; Tang W; Zhai X; Meng L; Guo H Acta Cardiol; 2016 Feb; 71(1):27-34. PubMed ID: 26853250 [TBL] [Abstract][Full Text] [Related]
7. Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study. Ikdahl E; Rollefstad S; Hisdal J; Olsen IC; Pedersen TR; Kvien TK; Semb AG PLoS One; 2016; 11(4):e0153440. PubMed ID: 27093159 [TBL] [Abstract][Full Text] [Related]
12. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease. Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007 [TBL] [Abstract][Full Text] [Related]
13. IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients. Milanez FM; Saad CG; Viana VT; Moraes JC; Périco GV; Sampaio-Barros PD; Goncalves CR; Bonfá E Arthritis Res Ther; 2016 Feb; 18():52. PubMed ID: 26912133 [TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism. Liuni A; Luca MC; Gori T; Parker JD J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516 [TBL] [Abstract][Full Text] [Related]
15. Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH). ter Avest E; Abbink EJ; Holewijn S; de Graaf J; Tack CJ; Stalenhoef AF Curr Med Res Opin; 2005 Sep; 21(9):1469-76. PubMed ID: 16197666 [TBL] [Abstract][Full Text] [Related]
16. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation. Liu M; Wang F; Wang Y; Jin R Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689 [TBL] [Abstract][Full Text] [Related]
18. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis. Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549 [TBL] [Abstract][Full Text] [Related]
19. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia. Nawawi H; Osman NS; Yusoff K; Khalid BA Horm Metab Res; 2003 Aug; 35(8):479-85. PubMed ID: 12953165 [TBL] [Abstract][Full Text] [Related]
20. Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study. Pan JE; Xiong FL; Chen G; Zhang ZW; Xu YJ Biomed Pharmacother; 2017 Nov; 95():1549-1555. PubMed ID: 28950654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]